|4Oct 8, 3:38 PM ET

GENEREX BIOTECHNOLOGY CORP 4

4 · GENEREX BIOTECHNOLOGY CORP · Filed Oct 8, 2014

Insider Transaction Report

Form 4
Period: 2014-10-06
FLETCHER MARK
EVP & General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2014-10-06$0.00/sh+470,726$471470,726 total
  • Exercise/Conversion

    Common Stock Purchase Option (Right to Buy)

    2014-10-06470,7260 total
    Exercise: $0.00From: 2005-04-05Exp: 2014-10-26Common Stock (470,726 underlying)

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT